Liquid Biospy for Urinary Cancers

Recruiting now

Conditions studied: Urothelial Carcinoma

In brief

The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.

Key facts

Study ID

NCT06116396

Run by

IRCCS San Raffaele

People needed

450

Starts

2020-09-29

Expected to finish

2028-09-29

Last updated by the study team

2023-11-07

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of urothelial neoplasia, naive for therapy

You may not qualify if…

• Absence of previous neolpastic disease or genetic diseases

Where it is running

• Urology Department — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.